SEC 13F Intelligence

Sofinnova Investments, Inc. / AXSM

Sofinnova Investments, Inc.’s Axsome Therapeutics Inc. Position

Does Sofinnova Investments, Inc. own Axsome Therapeutics Inc. (AXSM)? Yes — 212.7K shares worth $36M (+1.37% of its 13F portfolio) as of Q1 2026, up from 12.3K shares the prior filed quarter.

Position Value
$36M
Q1 2026
Shares
212.7K
% of Portfolio
+1.37%
Quarters Held
12
currently held

Position History AXSM

Reported value by quarter
Q1 ’20: $4MQ1 ’20Q2 ’20: $7MQ1 ’23: $7MQ1 ’23Q2 ’23: $13MQ3 ’23: $6MQ3 ’23Q3 ’24: $34MQ4 ’24: $42MQ4 ’24Q1 ’25: $20MQ2 ’25: $10MQ2 ’25Q3 ’25: $48MQ4 ’25: $2MQ4 ’25Q1 ’26: $36Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026212.7K$36M+1.37%
Q4 202512.3K$2M+0.10%
Q3 2025393.5K$48M+2.61%
Q2 202593.6K$10M+0.60%
Q1 2025175.3K$20M+1.34%
Q4 2024491.7K$42M+3.03%
Q3 2024379.5K$34M+2.71%
Q3 202380.4K$6M+0.35%
Q2 2023179.2K$13M+0.84%
Q1 2023120.9K$7M+0.48%
Q2 202087.0K$7M+0.45%
Q1 202073.2K$4M+0.40%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sofinnova Investments, Inc.’s full portfolio or all institutional holders of AXSM.